Alcatraz AI Named as Axis Communications Axis Technology Integration Partner
Companies will jointly market AI-powered facial authentication access control solutions to remove friction and make areas more secure
CUPERTINO, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Alcatraz AI, a global leader in autonomous access control solutions, today announced a partnership with Axis Communications to provide Alcatraz AI’s flagship facial authentication product, the Rock, as part of the Axis family of solutions that improve security and optimize business performance. Alcatraz AI is now a member of the Axis Technology Integration Partner (TIP) program.
"The way in which Alcatraz AI is transforming how people access buildings and secure areas aligns perfectly with the Axis vision of combining intelligent technology and human imagination to improve security and optimize business performance,” said Tina D’Agostin, CEO of Alcatraz AI. “We are proud to be accepted as an Axis Technology Integration Partner and look forward to demonstrating the value we can bring as we work together to enhance access control with their next generation of network door controllers.”
The Alcatraz AI Rock is a modern facial authentication solution that works natively with Axis Communications access control systems and door controllers to use a person’s face as their credential to quickly and privately authenticate users at the point of entry. Together Axis and Alcatraz deliver secure rapid authentication as a single-factor solution or access at the speed of single factor when used as part of a multi-factor system. The Rock’s intelligent tailgate detection can send alerts and actionable insights to Axis’ access control management software to reduce the threat of a breach due to tailgating and support compliance in zero trust environments.
The combination of Axis access control systems and the Rock’s simple and secure enrollment process improves efficiency and effectiveness for both administrators and users. Designed in compliance with the latest privacy frameworks, including General Data Protection Regulation (GDPR), the Illinois Biometric Information Protection Act (BIPA) and the California Consumer Privacy Act (CCPA), Axis channel partners and end customers now have an unmatched opportunity to manage and ensure privacy compliance.
“We are thrilled to have Alcatraz AI join our Axis Technology Integration Partner Program,” said Drew Pacino, Business Development Manager at Axis Communications. “Their facial authentication product is truly unique, and by integrating this with Axis devices can offer even more value to our mutual Channel Partners and end customers. We look forward to a successful collaboration with Alcatraz AI.”
The Axis Technology Integration Partner Program is designed for partners who already have a commercially-viable application or solution in the market, or one very close to commercial launch, and who provide business and product support to their customers. In addition to extensive technical support to ensure the seamless integration of partner solutions with Axis products, partners in the program benefit from a joint go-to-market strategy, including business and marketing resources and support.
About Alcatraz AI
Founded in 2016, Alcatraz AI uses AI and machine learning to deliver industry-leading facial authentication solutions to all access control systems to more effectively and efficiently keep people and spaces safe and secure. With its patented technology, Alcatraz AI’s facial authentication solution, intelligent tailgating detection, and simplified enrollment process works natively with existing access control systems to transform physical security and protect individual privacy. With a vision of simplicity, security, and privacy Alcatraz AI is trusted to protect more than one million employees at Fortune 500 companies.
For more information, please visit www.alcatraz.ai and follow @alcatrazai on Twitter and Alcatraz on LinkedIn.
Contact
Shannon Campbell
Offleash for Alcatraz AI
alcatrazai@offleashpr.com
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Fortuna files Form 40-F, Annual Report30.3.2023 23:15:00 CEST | Press release
VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) reports that the Company has filed today its fiscal 2022 annual report on Form 40-F with the U.S. Securities and Exchange Commission (“SEC”). The Form 40-F, which includes the Company’s fiscal 2022 annual audited financial statements, management’s discussion and analysis, and annual information form, is available on the Company’s website and on the SEC´s website. Printed copies of the annual financial statements are available free of charge to Fortuna shareholders upon written request. About Fortuna Silver Mines Inc. Fortuna Silver Mines Inc. is a Canadian precious metals mining company with four operating mines in Argentina, Burkina Faso, Mexico and Peru, and a fifth mine under construction in Côte d'Ivoire. Sustainability is integral to all our operations and relationships. We produce gold and silver and generate shared value over the long-term for our stakeholders through
Samlede antal stemmerettigheder og aktiekapital i Pharma Equity Group A/S ("Selskabet")30.3.2023 23:13:48 CEST | pressemeddelelse
Pharma Equity Group A/S Selskabsmeddelelse Årets meddelelse nr.: 24 Dato: 30. marts 2023 Samlede antal stemmerettigheder og aktiekapital i Pharma Equity Group A/S ("Selskabet") I henhold til Lov om kapitalmarkeder (lovbekendtgørelse nr. 41 af 13. januar 2023) § 32 offentliggør Selskabet hermed det samlede antal stemmerettigheder og den samlede aktiekapital i Selskabet. Efter kapitalforhøjelse registreret den 24. marts 2023 vedrørende udstedelse af vederlagsaktier til aktionærerne i Reponex Pharmaceuticals A/S og nye aktier med fortegningsret for Selskabets eksisterende aktionærer i en fortegningsretsemission, hvor Selskabet i alt udstedte 978.584.263 stk. nye aktier à nominelt DKK 1,00 pr. aktie, udgør Selskabets samlede nominelle aktiekapital DKK 1.022.963.883 svarende til 1.022.963.883 antal aktier og 1.022.963.883 stemmer pr. 31. marts 2023 Yderligere information Alle henvendelser vedrørende ovenstående bedes venligst rettet til direktør Peter Ole Jensen på e-mailadressen: peter.ole
Multitude Group Annual Report for 2022 published30.3.2023 22:45:00 CEST | Press release
Multitude Group Annual Report for 2022 published Helsinki, 30 March 2023 – Multitude SE (ISIN: FI4000106299, WKN: A1W9NS) (“Multitude” or the “Group”) is pleased to announce that the Group's Annual Report, Corporate Governance Statement and Remuneration Report for the year ended 31 December 2022 have been published today on the company’s website. The Annual Report consists of annual review and financial review, including Board of Directors‘ report, consolidated financial statements and parent company’s financial statements. The annual review includes the ESG Report 2022 which comprises the non-financial statement. It outlines the Group’s ESG Goals and KPIs focused on people, processes, and the environment, with commencement of reporting on the Group’s carbon emissions. The ESG report 2022 further highlights the Group’s commitment to customer well-being through responsible lending practices and the introduction of a Responsible Lending Index and a commitment to progress on employee well
Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion30.3.2023 22:45:00 CEST | Press release
Company announcement – No. 11 / 2023 Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES AND THE SECURITIES REFERRED TO HEREIN MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT; ANY PUBLIC OFFERING OF SUCH SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM THE ISSUER, WHICH WOULD CONTAIN DETAILED INFORMATION ABOUT THE COMPANY AND MANAGEMENT, AS WELL AS FINANCIAL STATEMENTS. As announced on 30 March 2023, Zealand Pharma commenced
Multitude SE: Notice to Convene Multitude SE's Annual General Meeting of Shareholders30.3.2023 22:45:00 CEST | Press release
NOTICE TO CONVENE MULTITUDE SE’S ANNUAL GENERAL MEETING OF SHAREHOLDERS Notice is given to the shareholders of Multitude SE (Company) that the Annual General Meeting of the Company is to be held on 27 April 2023 at 10:00 a.m. (EEST / Finnish time) at the offices of Castrén & Snellman Attorneys Ltd, Eteläesplanadi 14, Helsinki, Finland. The reception of persons who have registered for the meeting and the distribution of voting tickets will start at 9:30 a.m. (EEST / Finnish time). Shareholders may also exercise their voting rights by voting in advance. Instructions concerning advance voting are provided in Section 3.4 of this notice. It will not be possible to participate in the meeting or follow the meeting via an online stream or otherwise in real time by the use of telecommunication connections or technical means. The meeting will be held in the English language. 1 MATTERS ON THE AGENDA OF THE GENERAL MEETING OF SHAREHOLDERS At the General Meeting of Shareholders, the following matte